INTERNATIONAL PATENT: RNA GUARDIAN LTD FILES APPLICATION FOR "DETERMINATION OF OVARIAN CANCER STATUS BASED ON LARP1 AND CA125 EXPRESSION"

GENEVA, May 12 -- RNA GUARDIAN LTD (Lynton House53 WoodgreenWitney Oxfordshire OX28 1DB) filed a patent application (PCT/GB2024/052767) for "DETERMINATION OF OVARIAN CANCER STATUS BASED ON LARP1 AND CA125 EXPRESSION" on Oct 31, 2024. With publication no. WO/2025/093876, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BLAGDEN, Sarah (c/o RNA Guardian LtdLynton House53 WoodgreenWitney Oxfordshire OX28 1DB)

Abstract: The invention relates to the measurement of both LARP1 and CA125 levels in a biological sample of a subjec...